Atopic dermatitis (AD) is the most common form of eczema in the UK affecting 5-10% of all adults. There isn’t one single cause of AD but it is thought to be down to a combination of immune system problems and genetics.

From the financial costs of medications to an increased risk of developing depression, the costs of AD to many patients are wide-ranging and detrimental to their quality of life, particularly for patients from lower socioeconomic backgrounds.

This report aims to investigate and raise awareness of these costs, and sets out recommendations on how to improve patient care in order to help reduce these costs.